Loading
Guide to EU and UK Pharmaceutical Regulatory Law, Ninth Edition

Guide to EU and UK Pharmaceutical Regulatory Law, Ninth Edition

SKU:10059161-0003
Sally Shorthose, Pieter Erasmus
For general delivery times, please see our shipping policy
Price:
$270.00
Product Line
Kluwer Law International
ISBN-13
9789403511191
Availability
Ships in 5-7 Business Days
Last Updated
2025-10-3

Overview

Guide to EU and UK Pharmaceutical Regulatory Law, currently in its ninth edition, is a useful book outlining this system with extraordinary clarity and logic. Embracing a Europe-wide perspective on the law governing pharmaceuticals, adept contributors from the law firm Bird & Bird LLP map the life cycle of a medicinal product or medical device from development to clinical trials to product launch and ongoing pharmacovigilance, offering comprehensive and unambiguous guidance at every stage. In the European Union (EU), its Member States and the United Kingdom (UK) post-Brexit, as elsewhere, the marketing of pharmaceuticals is subject to an ever more complex web of legislation and regulation, resulting from the intense scrutiny necessary to ensure that such essential products are not only efficacious but also safe.


What’s in this book:

Succeeding the brief introductory chapters that provide an overview of the regulatory framework for pharmaceuticals in Europe, a short discussion of how the overarching EU regulatory regime is poised to change in the coming years, and how the exit from the EU by the UK currently affects the regulatory regime, each of the following (twenty-one) incisive chapters examines a particular process or subject. Among the many topics and issues covered from both an EU and UK perspective – including the all-new chapter on artificial intelligence – are the following: 

  • clinical trials;
  • stages and standards for creating a product dossier;
  • obtaining a marketing authorisation;
  • how and when an abridged marketing authorisation procedure can be used;
  • criteria for conditional marketing authorisations;
  • generic products and ‘essential similarity’;
  • paediatric use and the requisite additional trials;
  • orphan medicinal products;
  • biologicals and ‘biosimilars’;
  • homoeopathic, herbal and similar medicines;
  • medical devices;
  • pandemics, epidemics and vaccines;
  • pharmacovigilance;
  • parallel trade;
  • advertising; and
  • relevant competition law, intellectual property rights and data protection regulation.

How this will help you:

This unique book will be highly appreciated by pharmaceutical lawyers and regulatory advisers, both in-house and in private practice. It will prove invaluable for all who need to understand the process of bringing a medicinal product or medical device to market and the continuing rights and obligations.

Table Of Contents

About the Editors and Authors


List of Abbreviations


Preface


CHAPTER 1

Overview of European Pharmaceutical Regulatory Requirements

Sally Shorthose


CHAPTER 2

EU Pharma Package

Sally Shorthose


CHAPTER 3

Brexit

Sally Shorthose


CHAPTER 4

Overview of Intellectual Property Rights

Sally Shorthose, Annika Lückemann, Andrzej Stelmachowski & Sophie Vo


CHAPTER 5

Clinical Trials

Sally Shorthose, Pieter Erasmus, Ana-Maria Barbu-Nyström, Anna Koster & Maud van Haaren


CHAPTER 6

Obtaining a Marketing Authorisation

Sally Shorthose, Sarah Faircliffe & Phillipus Putter


CHAPTER 7

Conditional Marketing Authorisations

Sally Shorthose & Phillipus Putter


CHAPTER 8

Supplementary Protection Certificates

Annika Lückemann, Jan van Dieck, Sophie Vo, Andrzej Stelmachowski & Mark Day


CHAPTER 9

Paediatrics

Sally Shorthose, Sarah Faircliffe & Pieter Erasmus


CHAPTER 10

Advertising Medicinal Products for Human Use

Hester Borgers, Marc Martens, Benedicte Mourisse, Sofia Paksuniemi, Johanna Harelimana, Caroline Arrighi-Savoie, Christian Lindenthal, Annelie Säurig, Denis Halton, Mauro Turrini, Maria Jurek, Andrzej Stelmachowski, Coral Ya´ñez, Alejandra Ine´s Vicario Calleja, Gunnar Hjalt, Ana-Maria Barbu-Nyström & Pieter Erasmus


CHAPTER 11

Pharmacovigilance

Sally Shorthose, Pieter Erasmus, Johanna Harelimana & Nour Saab


CHAPTER 12

Variations to Marketing Authorisations

Caroline Arrighi-Savoie, Johanna Harelimana & Phillipus Putter


CHAPTER 13

Abridged Procedure

Caroline Arrighi-Savoie, Johanna Harelimana & Pieter Erasmus


CHAPTER 14

Orphan Medicinal Products

Sarah Faircliffe & Pieter Erasmus


CHAPTER 15

Biopharmaceuticals

Marc Martens, Benedicte Mourisse & Patrick Brown


CHAPTER 16

Homeopathic, Herbal, and Traditional Herbal Medicinal Products and Cannabis-Based Medicinal Products

Pieter Erasmus, Christian Lindenthal & Annelie Säurig


CHAPTER 17

Advanced Therapy Medicinal Products

Marc Martens, Benedicte Mourisse & Patrick Brown


CHAPTER 18

Vaccines

Sally Shorthose & Phillipus Putter


CHAPTER 19

Medical Devices

Kevin Munungu, Sophie Vo, Maria Jurek, Andrzej Stelmachowski, Kelly Mackey & Maarten Princen


CHAPTER 20

Parallel Trade

Christian Lindenthal, Pieter Erasmus & Annelie Säurig


CHAPTER 21

Competition Law in the Pharmaceutical Sector

Morten Nissen, Peter Willis & Alexander Brøchner


CHAPTER 22

Pandemics and Epidemics

Hester Borgers, Maud van Haaren & Phillipus Putter


CHAPTER 23

Data Protection in the Pharmaceutical Sector

Clara Clark Nevola & Emma Drake


CHAPTER 24

Artificial Intelligence in the Pharmaceutical and Medical Devices Sector

Deirdre Kilroy, Christian Lindenthal, Hester Borgers, Kelly Mackey, Edzard Boonen & Maud van Haaren


Appendix: Guidelines and Publications


Table of Cases


EU Directives


Other Legislation


EU Regulations


Index

Experts

  • Sally Shorthose
    Sally Shorthose
    Bird & Bird
    Partner
    Sally has a wealth of experience working with businesses at the cutting edge of research and technology and whose intellectual property is of prime importance.
Loading
Guide to EU and UK Pharmaceutical Regulatory Law, Ninth Edition | Wolters Kluwer Legal & Regulatory